R.F. Palm

1 ta ish

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

1. Benefit of Adjuvant Chemotherapy for Resected Pancreatic Cancer Following Neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: A Multinational Analysis

   V. Lopez Lopez, T. Hasse, E. Rangelova +18

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.116378